119 results
424B3
PHIO
Phio Pharmaceuticals Corp
28 Dec 23
Prospectus supplement
9:13am
, Massachusetts 01752 Attention: Investor Relations, telephone: (508) 767-3861. We maintain a website at www.phiopharma.com. You may access our definitive
8-K
EX-10.1
ukdys5uxflt
26 Jul 23
Departure of Directors or Certain Officers
4:30pm
424B3
8ncmiy7uwuu4o5
20 Jun 23
Prospectus supplement
9:30am
DEFA14A
hv1 6xecyv1d
9 Jun 23
Additional proxy soliciting materials
4:31pm
8-K
EX-10.1
5f54jfo7gkmkf3f6
2 Jun 23
Phio Pharmaceuticals Announces $4 Million Concurrent Registered Direct
4:30pm
8-K
EX-10.3
07uyosck9g4yhd 88i
2 Jun 23
Phio Pharmaceuticals Announces $4 Million Concurrent Registered Direct
4:30pm
8-K
EX-10.2
9q5277lwtsh 8if
2 Jun 23
Phio Pharmaceuticals Announces $4 Million Concurrent Registered Direct
4:30pm
424B5
1n85y5cvg5rzy
1 Jun 23
Prospectus supplement for primary offering
5:00pm
424B3
kw4oxba v3pvoaa
10 May 23
Prospectus supplement
4:30pm
8-K
EX-10.1
99iv yn5wdc74
20 Apr 23
Phio Pharmaceuticals Announces $2 Million Registered Direct
2:53pm
424B5
dmbnfcfffsit5wpxq
19 Apr 23
Prospectus supplement for primary offering
5:06pm